Colony Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,299
| Closed | -$725K | – | 776 |
|
|
2019
Q3 | $725K | Buy |
7,299
+179
| +3% | +$17K | 0.02% | 420 |
|
|
2019
Q2 | $658K | Buy |
7,120
+122
| +2% | +$11.6K | 0.02% | 454 |
|
|
2019
Q1 | $660K | Buy |
+6,998
| New | +$612K | 0.03% | 344 |
|
|
2018
Q4 | – | Sell |
-3,220
| Closed | -$288K | – | 561 |
|
|
2018
Q3 | $288K | Sell |
3,220
-77
| -2% | -$6.8K | 0.01% | 420 |
|
|
2018
Q2 | $262K | Sell |
3,297
-411
| -11% | -$34.1K | 0.01% | 432 |
|
|
2018
Q1 | $331K | Sell |
3,708
-153
| -4% | -$14.7K | 0.02% | 381 |
|
|
2017
Q4 | $403K | Buy |
3,861
+94
| +2% | +$10.6K | 0.03% | 349 |
|
|
2017
Q3 | $549K | Sell |
3,767
-69
| -2% | -$9.4K | 0.04% | 279 |
|
|
2017
Q2 | $498K | Buy |
3,836
+1,173
| +44% | +$144K | 0.04% | 288 |
|
|
2017
Q1 | $331K | Sell |
2,663
-503
| -16% | -$60.2K | 0.03% | 225 |
|
|
2016
Q4 | $366K | Buy |
3,166
+98
| +3% | +$10.9K | 0.04% | 218 |
|
|
2016
Q3 | $321K | Sell |
3,068
-16,015
| -84% | -$1.73M | 0.04% | 212 |
|
|
2016
Q2 | $1.88M | Sell |
19,083
-97,236
| -84% | -$10.1M | 0.21% | 106 |
|
|
2016
Q1 | $11.6M | Sell |
116,319
-1,917
| -2% | -$197K | 1.35% | 25 |
|
|
2015
Q4 | $14.2M | Buy |
118,236
+1,241
| +1% | +$144K | 1.29% | 20 |
|
|
2015
Q3 | $12.7M | Buy |
116,995
+1,396
| +1% | +$173K | 1.47% | 15 |
|
|
2015
Q2 | $13.4M | Buy |
115,599
+2,005
| +2% | +$229K | 1.41% | 18 |
|
|
2015
Q1 | $13.1M | Sell |
113,594
-16,550
| -13% | -$1.98M | 1.45% | 15 |
|
|
2014
Q4 | $14.6M | Buy |
130,144
+15,031
| +13% | +$1.59M | 1.52% | 12 |
|
|
2014
Q3 | $10.9M | Sell |
115,113
-415
| -0.4% | -$37.5K | 1.22% | 23 |
|
|
2014
Q2 | $9.92M | Sell |
115,528
-16,090
| -12% | -$1.22M | 1.32% | 31 |
|
|
2014
Q1 | $9.19M | Sell |
131,618
-2,090
| -2% | -$166K | 1.24% | 33 |
|
|
2013
Q4 | $11.3M | Buy |
+133,708
| New | +$10.6M | 1.57% | 19 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Colony Group's CELG Position: Q4 2019 in Review
Colony Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,299 shares — an estimated $725K sold.
Colony Group first reported a position in CELG in Q4 2013 and held it in 23 quarters. The position peaked at $14.6M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Colony Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Colony Group sold 7,299 Celgene Corp shares in Q4 2019, an estimated $725K.
- Colony Group first reported a position in Celgene Corp in Q4 2013 and held it in 23 quarters.
- Colony Group's Celgene Corp position peaked at $14.6M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Colony Group's 13F filing for Q4 2019, filed 18 Feb 2020.